Meeting
2015 ASCO Annual Meeting
Determinants for no definitive therapy for early-stage non-small cell lung cancer in U.S. population.
Authors
Yu-Wei Chen
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA
Yu-Wei Chen , Angela Y. Chang , Chen-Hao Chen , Yu-Han Chiu , Yen-Chen Feng , Sheng-Hsuan Lin , Yi-Han Sheu , Yen-Fen Lin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Etiology/Epidemiology
Citation
J Clin Oncol 33, 2015 (suppl; abstr 1590)
DOI
10.1200/jco.2015.33.15_suppl.1590
Abstract #
1590
Poster Bd #
414
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Rates of surgery and adjuvant chemotherapy use in patients with stage IB to IIIA non-small cell lung cancer: A provincial population-based study.
First Author: Yuchen Li
Poster
2023 ASCO Annual Meeting
Stereotactic ablative radiotherapy with nivolumab for early-stage operable non-small cell lung cancer: A phase 2 study.
First Author: Gustavo Schvartsman
Poster
2022 ASCO Quality Care Symposium
Physician referral patterns and use of adjuvant therapy among patients with stage IB-IIIA non–small cell lung cancer (NSCLC) (2010-2017).
First Author: Hrishikesh Kale
Poster
2016 Palliative and Supportive Care in Oncology Symposium
Impact of cachexia at diagnosis on radiotherapy utilization and survival in non-small cell lung cancer.
First Author: Steven Lau